1. Brachman, CB, Sherman, JM, Devine, SE & Cameron, EE (1995). The Sir2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Gene Dev, 9: 2888–2902.
2. Califano, D, Monaco, C, Santelli, G, Giuliano, A, Veronese, ML, Berlingieri, MT, de Franciscis, V, Berger, N, Trapasso, F, Santoro, M, Viglietto, G & Fusco, A (1998). Thymosin β-10 Gene overexpression correlates with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res, 58: 823–828.
3. Cerutti, J, Trapasso, F, Battaglia, C, Zhang, Li, Martelli, ML, Berlingieri, MT, Fagin, J, Santoro, M & Fusco, A (1996). Blockage of c-MYC protein synthesis in human thyroid carcinoma cell lines reduces their growth in soft agar. Clin Cancer Res, 2: 119–126.
4. Chiappetta, G, Berlingieri, MT, Manfioletti, G, Santoro, M, Bandiera, A, Visconti, R, Giancotti, V & Fusco, A (1995). The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene, 10: 1307–1314.
5. Chiariotti, L, Berlingieri, MT, Berger, N, De Rose, P, Battaglia, C, Bruni, CB & Fusco, A (1993). Increased expression of the negative growth factor, galactoside binding protein gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene, 7: 2507–2511.